Placebo-controlled trial of risperidone augmentation for SSRI [selective serotonin reuptake inhibitor]-resistant civilian PTSD [post-traumatic stress disorder]

Trial Profile

Placebo-controlled trial of risperidone augmentation for SSRI [selective serotonin reuptake inhibitor]-resistant civilian PTSD [post-traumatic stress disorder]

Completed
Phase of Trial: Phase II/III

Latest Information Update: 05 Nov 2014

At a glance

  • Drugs Risperidone; Sertraline
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Nov 2014 Last checked against ClinicalTrials.gov record.
    • 08 Jan 2007 Status change
    • 03 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top